Back

ESMO Plenary May 2022 - ESMO Virtual Plenaries: May 2022

May 19 - May 20, 2022 | LuganoSwitzerland

LARVOL is not affiliated with ESMO Virtual Plenaries: May 2022 and all trademarks, logos, and brand names are property of their respective owners

Condition
Stage
Treatment
Setting
Biomarker
Trial Name/ID

Showing 1 abstracts linked to Trials

Updated progression-free survival (PFS) and depth of response in IKEMA, a randomized phase III trial of isatuximab, carfilzomib and dexamethasone (Isa-Kd) vs Kd in relapsed multiple myeloma (MM)